C4 Therapeutics, Inc. (CCCC:NASDAQ) closed at $3.22 on October 27, 2026, up 7.89% on the day. The stock trades 37.8% below its 52-week high of $5.17 and 90.2% above its 52-week low of $1.69. Over the past year, it gained 12.5%. C4 Therapeutics, Inc. is part of the Health Care sector.
In 252 trading sessions since October 24, 2025, CCCC closed higher on 118 days (47%). Its best day was May 29, 2026 (+19.40%) and its worst was March 10, 2026 (-13.09%). The stock moved 10% or more in a single session 12 times.
C4 Therapeutics Inc is a bio-pharmaceutical company. The company is focused on harnessing the body's natural regulation of protein levels to develop novel therapeutic candidates to eliminate disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.
Find more stocks like CCCC with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.